Sidransky David
SEC-identified person · CIK 1277161 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Ascentage Pharma Group International AAPG | Director | filed 2026 - 2026 |
| Galmed Pharmaceuticals Ltd. GLMD | Director | filed 2026 - 2026 |
| Champions Sports INC csbr | Director · Chairman of the Board | filed 2007 - 2025 |
| Orgenesis Inc. ORGS | Director | filed 2018 - 2023 |
| Ayala Pharmaceuticals, Inc. ADXS | Director | filed 2013 - 2023 |
| Old Ayala, Inc AYLA | Director | filed 2020 - 2023 |
| Cactus Acquisition Corp. 1 Ltd CCTSU | Director | filed 2021 - 2021 |
| Immune Pharmaceuticals INC IMNPQ | Director | filed 2013 - 2015 |
| Celsus Therapeutics Plc. CLTX | Director | filed 2015 - 2015 |
| KV Pharmaceutical CO /DE/ kva/kvb | Director | filed 2010 - 2013 |
| Tamir Biotechnology, Inc. ACEL.PK | Director | filed 2006 - 2012 |
| Zila INC ZILAD | Director | filed 2006 - 2007 |
| Imclone Systems INC/DE IMCL | Director | filed 2006 - 2006 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.